Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs. by nantkweststg | Feb 12, 2021
The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex. by nantkweststg | Feb 12, 2021
Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy. by nantkweststg | Feb 12, 2021
Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy. by nantkweststg | Feb 12, 2021
Final results from a phase 2 study using off-the-shelf activated natural killer (aNK) Cells in combination with N-803, an IL-15 superagonist, in patients with metastatic Merkel cell carcinoma (MCC) by nantkweststg | Jan 28, 2021
Recent Comments